Caigang Liu

机构：China Medical University · ORCID：0000-0003-2083-235X

发表论文 274 篇 · 总被引 4362 次 · h-index 37

代表论文

• Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy (2025 · Advanced Science · 被引 16)
• TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study (2025 · Cancer Cell · 被引 10)
• From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies (2025 · Bioactive Materials · 被引 7)
• Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial (2025 · Nature Communications · 被引 6)
• CD8+ TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patients (2025 · Signal Transduction and Targeted Therapy · 被引 5)
• ASO Visual Abstract: Surgical and Oncologic Outcomes of Tumescence and Sharp Dissection Versus Electrocautery Dissection in Minimal Access Nipple-Sparing Mastectomy with Immediate Prosthesis Breast Reconstruction: A Real-World Retrospective Cohort Study (2025 · Annals of Surgical Oncology · 被引 1)